A 32-year-old man with lung cancer involving pericarditis carcinomatosa underwent pericardiotomy, using an Inoue balloon dilating catheter, to create a non-surgical pericardial window. The procedure was performed from the thoracic wall to the left pleural effusion and parietal pericardium under local anesthesia. The effects of non-surgical pericardial window had been maintained until this patient died from his primary disease. It is concluded that percutaneous balloon pericardiotomy is helpful in the management of massive pericardial effusions particularly in patients with malignancies and poor clinical condition.
Introduction
Malignancy is one of the commoncauses of pericardial effusion with tamponade, tachyarrhythmias, or congestive heart failure. The incidence of metastatic malignancies to the myocardium and the pericardium has been described from less than 1%to more than 20%of all cancer patients and this incidence varies with the type of malignancy (1) (2) (3) (4) . The managementof pericardial effusion in patients with malignancy is an important problem that confronts both the oncologist and the cardiologist. The prognosis of patients with malignant cardiac tamponade is related to early diagnosis and treatment of tamponade. A commonproblem is that malignant pericardial effusions reaccumulate rapidly and call for more radical treatment. The recommendedtherapy for recurrent malignant pericarditis has been described to be either multiple pericardiocentesis accompanied by instillation of chemotherapeutic drugs or the ereation of a subxiphoid surgical window(5-7). Surgical evacuation of pericardial effusion under pressure can be accomplished with various techniques (8-1 1 ). Such techniques are performed under general anesthesia. However a 30-day mortality rate has been reported (9) with this procedure in up to 60%of documented cases. This probably reflects the severity of the systemic illness. For this reason, surgery should be avoided if possible. In 1991, Palacios et al (12) first described percutaneous balloon pericardiotomy and demonstrated its effectiveness and relatively low risk. Later, Chow and Chow (13) reported the use of the Inoue balloon catheter for this procedure. The technique of percutaneous balloon pericardiotomy is less invasive than surgery and has moreconstant positive effects than pericardiocentesis. Wedescribe our experience of percutaneous balloon pericardiotomy using the Inoue balloon in the management of malignant pericardial effusion induced by lung cancer.
Case Report
A 32-year-old man with non-small cell (adenocarcinoma) lung cancer was admitted to our hospital with malignant pericardial effusion (Fig. 1 ). An urgent pericardiocentesis through the subxiphoid approach was performed. Following removal of 1,020 ml of bloody pericardial fluid, cisplatin was administrated into the pericardium to prevent a recurrence of pericardial effusion. The cytology of the pericardial effusion revealed adenocarcinoma. Subsequently, he received systemic chemotherapy consisting of 2 cycles of a combination of cisplatin 80 mg/m2, once daily i.v. on day 1 and etoposide 100 mg/m2, once daily i.v. on days 1, 2, and 3, but the size of the main tumor of the lung became enlarged. Six months later, the patient was admitted again with cardiac tamponadedue to reaccumulation of pericardial effusion. Echocardiography confirmed the development of moderate pericardial effusion only behind his heart with left ventricular collapse (Fig. 2 ). An urgent pericardiocentesis was performed through the left pleural effusion approach. Following removal of 600 ml of bloody peri- cardial fluid, continuous drainage could be achieved by placing a pigtail catheter in the pericardial space, but the effusion was not controllable. To avoid a new development of cardiac tamponade, we decided to create a pericardial windowby employing the percutaneous balloon pericardiotomy method described by Chowand Chow (13) . In brief, after administration of local anesthesia a 0.025 inch guide-wire was inserted into the pericardial space from the left chest wall through the pigtail catheter. A 12 french dilator was advanced over the guidewire, through the thoracic wall, left pleural effusion and parietal pericardium. A self-positioning catheter, the Inoue balloon catheter set (Toray Medical Co. Ltd., Tokyo, Japan) at 22 mm, was exchanged over the guide-wire and advanced into the pericardial space under fluoroscopy. The distal portion of the balloon was inflated first and the catheter was then pulled back gently until the distal balloon anchored itself at the parietal pericardium (Fig. 3) . The balloon was then rapidly inflated to Percutaneous Balloon Pericardiotomy its full extent until the waist disappeared (Fig. 4) . It was kept inflated for 1 minute. Three inflations were performed to ensure adequate opening of the pericardium. After this procedure, werecognized that contrast mediumwaswashedout from the pericardial space to the pleural cavity. Follow-up on the patient was performed via echocardiograph for seven months after this procedure. Nosigns of reaccumulation of the malignant pericardial effusion were observed. Hedied of respiratory failure due to lung cancer.
Discussion
Recently, balloon pericardiotomy has been proposed as a useful and less invasive therapy whichis an alternative to surgical pericardiotomy ( 14-1 8) . This technique can be performed even in critically ill patients with malignant pericardial tamponade, with a high rate of procedural success. Ziskind et al ( 1 9) already reported the effectiveness of creating a pericardial windowwith percutaneous balloon pericardiotomy and described a success rate of 93%with no severe complications except for 3% displaying fever and 1% showing pneumothorax. In Europe and America, several authors have reported the usefulness of this procedure, whereas there have been no such case reports compiled in Japan. The frequency of the recurrent pericardial effusion with pericarditis carcinomatosa is comparatively little. However, the recurrent pericardial effusion is often localized, and occasionally recurs over 6 months after the first drainage. Here, we performed pericardiotomy by using the Inoue balloon to treat recurrent pericardial effusion induced by lung cancer. During the inflating of the balloon, no clinical changes, including heart rates and blood pressure, were observed. As mentioned in manyprevious reports, the procedure is simple and safe and could be performed under local anesthesia and mild sedation. However, in Japan the indication of this procedure cannot be the first choice, due to the high cost of the Inoue balloon. Wesuggested that the indication of balloon pericardiotomy should be restricted to cases of cardiac tamponade suffering recurrence of localized pericardial effusion in spite of extensive efforts of drainage by using a pigtail catheter or cases not allowing further insertion of drainage catheter at the next recurrence of effusion. Although our patient had recurrent pericardial effusions localized posterior to his heart, we could insert a pigtail catheter without injuring the lung because of the presence of pleural effusion. But it proved difficult to do a second insertion. Therefore, we performed the pericardiotomy by using the Inoue balloon. The technique is relatively simple, safe, and can be performed under local anesthesia and mild sedation, with minimal discomfort even in critically ill patients. Previous reports (14) (15) (16) 18 ) described that the balloon should be inflated two to three times. For this procedure, we performed three inflations to ensure an adequate opening of the pericardium. Confirmationestablished that contrast mediumwas washed out from the pericardial space to the pleural cavity. To data, the efficacy of balloon pericardiotomy versus pericardiocentesis as a primary treatment for malignant pericardial effusion is still unknown. But it may become the preferred treatment to avoid moreinvasive procedures for patients with a limited life expectancy.
Conclusion
Wehave presented a case of recurrent cardiac tamponade treated with percutaneous balloon pericardiotomy by the use of the Inoue balloon. The patient reaccumulated fluid following pericardiocentesis, but we achieved good long-term results with balloon pericardiotomy. During the seven months of follow-up, his pericardial effusion did not significantly reaccumulate. Percutaneous balloon pericardiotomy helps to manage pericardial effusion and improve the quality of life. The procedure is relatively simple, safe and can be performed under local anesthesia and mild sedation.
